Skip to main content
Clinical Trials/RBR-3rdhgm
RBR-3rdhgm
Recruiting
未知

The role of early acute renal support in the prognosis of patients diagnosed of COVID-19: a randomized clinical trial

Departamento de Clínica Médica da Faculdade de Medicina de Botucatu0 sitesMay 14, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Coronavirus infection, unspecified
Sponsor
Departamento de Clínica Médica da Faculdade de Medicina de Botucatu
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 14, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Departamento de Clínica Médica da Faculdade de Medicina de Botucatu

Eligibility Criteria

Inclusion Criteria

  • patients over 18 years old; COVID\-19 positive by the RT\-PCR technique or rapid test; in mechanical ventilation; diagnosis of AKI; hydric balance positive higher then 3% of body weight; hospitalized in the ICU;vusing norepinephrine at a dose of 0\.1 to 1 µg / kg / min.

Exclusion Criteria

  • Pregnant patients; patients who were on other types of dialysis support, other than HDP or HDC, that with an emergency indication for RAS; diagnosed with stage 5 chronic kidney disease or need for chronic renal replacement therapy (dialysis or transplantation) will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials